SpringWorks Therapeutics, Inc. (SWTX)

NASDAQ: SWTX · IEX Real-Time Price · USD

44.20

+0.82 (1.89%)

At close: Apr 25, 2024, 4:00 PM

44.00

-0.20 (-0.45%)

After-hours: Apr 25, 2024, 6:10 PM EDT

SpringWorks Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-325.1	-277.42	-173.91	-45.57	-50.58	-17.81
Depreciation & Amortization	3.32	1.9	1.48	1.4	0.19	0.02
Share-Based Compensation	94.53	72.97	38.44	10.03	3.11	1.07
Other Operating Activities	4.46	40.99	6.11	1.95	7.56	2.56
Operating Cash Flow	-222.8	-161.56	-127.88	-32.19	-47.44	-14.17
Capital Expenditures	-7.39	-10.2	-2.02	-0.64	-0.67	-0.29
Acquisitions	-2.8	-4.2	0	-3.5	-3.59	0
Change in Investments	44.94	-201.2	85.61	-414.69	0	0
Investing Cash Flow	34.75	-215.6	83.59	-418.83	-4.26	-0.29
Share Issuance / Repurchase	296.64	340.7	1.16	270.49	169.75	0
Other Financing Activities	-	-	-	-	163.96	50.38
Financing Cash Flow	296.64	340.7	1.16	270.49	333.71	50.38
Net Cash Flow	108.6	-36.46	-43.13	-180.54	282	35.92
Free Cash Flow	-230.18	-171.76	-129.89	-32.83	-48.11	-14.46
Free Cash Flow Margin	-4225.81%	-	-	-93.81%	-	-
Free Cash Flow Per Share	-3.65	-3.22	-2.68	-0.76	-3.62	-42.40

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).